A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions.
Completed
Photocure
Phase 1/Phase 2
2006-08-01
The study will determine the best drug (MAL or HAL) dosage for photodynamic therapy of
cervical precancerous lesions (dysplasia) in women that are referred for conisation
(surgery).
Comparison of Metvix Photodynamic Therapy (PDT) With Its Vehicle in the Treatment of Photoaged Skin
Completed
Galderma R&D
Phase 2
2007-04-18
Skin photoaging or skin photodamage were terms used to describe the change in the structure,
function and appearance of skin caused by prolonged and repeated exposure to sunlight or
other ultraviolet light sources.
The visible effects of skin photodamage were fine lines, skin sagging, skin roughness, liver
spots and also the appearance of red patches made up of thin red vessels (called
telangiectasia).
More and more people were presenting to doctors with concerns about skin photodamage and the
demand for corrective procedures was increasing.
Metvix photodynamic therapy (Metvix PDT) is a procedure currently marketed in several
countries in Europe (including the United Kingdom [UK] and Spain) and in Australia, for the
treatment of benign forms of skin cancer (example, actinic keratosis).
The aim of the study was to assess whether Metvix PDT would be effective in correcting the
effects related to photodamage and whether it would be well tolerated.
Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease
No longer available
Galderma
1969-12-31
The aim of this study is to provide this investigational drug to patients who cannot be
optimally treated with conventional therapies and to collect efficacy and safety data on the
use of Metvix PDT in subjects with field actinic keratoses, large/multiple superficial basal
cell carcinomas (BCCs) or Bowen's disease.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
